Radiology

MRI Cardiac and MRA with Ferahem

Common conditions:

  • Congenital heart disease
  • Venous thrombosis
  • Aortic aneurysm
  • Celiac artery compression in median arcuate ligament syndrome
  • Peripheral vascular disease
  • Peripheral artery disease
  • Renal transplant evaluation

What are some key elements of this study?

  • Consent for the administration of Ferumoxytol
  • Slow intravenous administration of Ferumoxytol with oxygen and heart rate monitoring
  • Post-contrast breathheld and free breathing imaging
  • May include EKG-gated MRA
  • Why this modality?
  • Avoids requirement for gadolinium in patients with renal failure
  • Provides steady state vascular imaging for optimal arterial and venous enhancement throughout the examination
  • Non-nephrotoxic contrast

Who reads these studies?

Cardiac radiologists

What to do if there is a finding?

Followup with referring physician

Why get this done at UCLA Radiology?

  • One of few sites in the region to offer imaging with Ferumoxytol
  • Site of the Ferumoxytol imaging registry with vast experience in safely imaging with Ferumoxytol
  • Advanced post-processing with 3D volumetric renderings and 4D flow analysis
  • Experienced with complex congenital heart disease
  • Highly skilled MR technologists with onsite physician oversight